The Journey to Next-Generation ADCs: LCB’s Platform, Pipeline & What’s Next

• Overview of LCB's ConjuAll™ platform, the technology powering next-generation ADCs
• Highlighting updates on LCB's key drugs in clinical development
• Preclinical efficacy of newly clinical-stage candidates shaping LCB's future pipeline

Speakers:

Chul Woong Chung

Chief Technology Officer

LigaChem Biosciences